286 related articles for article (PubMed ID: 17376039)
1. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients.
Park JW; Jeong G; Kim SJ; Kim MK; Park SM
J Gastroenterol Hepatol; 2007 Apr; 22(4):491-7. PubMed ID: 17376039
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
4. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
6. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
[TBL] [Abstract][Full Text] [Related]
7. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.
Uchino S; Yamaguchi Y; Furuhashi T; Wang FS; Zhang JL; Okabe K; Kihara S; Yamada S; Mori K; Ogawa M
J Surg Res; 2004 Jul; 120(1):73-82. PubMed ID: 15172192
[TBL] [Abstract][Full Text] [Related]
8. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
[TBL] [Abstract][Full Text] [Related]
10. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
11. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
12. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.
Asanuma T; Ono M; Kubota K; Hirose A; Hayashi Y; Saibara T; Inanami O; Ogawa Y; Enzan H; Onishi S; Kuwabara M; Oben JA
Gut; 2010 Feb; 59(2):258-66. PubMed ID: 19919948
[TBL] [Abstract][Full Text] [Related]
13. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.
Satoh D; Yagi T; Nagasaka T; Shinoura S; Umeda Y; Yoshida R; Utsumi M; Tanaka T; Sadamori H; Fujiwara T
World J Hepatol; 2013 Apr; 5(4):189-95. PubMed ID: 23671723
[TBL] [Abstract][Full Text] [Related]
14. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
Pais R; Charlotte F; Fedchuk L; Bedossa P; Lebray P; Poynard T; Ratziu V;
J Hepatol; 2013 Sep; 59(3):550-6. PubMed ID: 23665288
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I
Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293
[TBL] [Abstract][Full Text] [Related]
17. Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH.
Erkan G; Yilmaz G; Konca Degertekin C; Akyol G; Ozenirler S
Pathol Res Pract; 2013 Jul; 209(7):429-32. PubMed ID: 23707549
[TBL] [Abstract][Full Text] [Related]
18. Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men.
Kim JK; Chon NR; Lim HC; Lee KS; Han KH; Chon CY; Park YN; Paik YH
J Gastroenterol Hepatol; 2012 Jan; 27(1):142-8. PubMed ID: 21883454
[TBL] [Abstract][Full Text] [Related]
19. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.
Canbakan B; Senturk H; Tahan V; Hatemi I; Balci H; Toptas T; Sonsuz A; Velet M; Aydin S; Dirican A; Ozgulle S; Ozbay G
Acta Gastroenterol Belg; 2007; 70(3):277-84. PubMed ID: 18074737
[TBL] [Abstract][Full Text] [Related]
20. CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation.
Tonan T; Fujimoto K; Qayyum A; Morita Y; Nakashima O; Ono N; Kawahara A; Kage M; Hayabuchi N; Ueno T
J Gastroenterol Hepatol; 2012 Apr; 27(4):789-96. PubMed ID: 22188204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
